Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Coleman

Showing results (751-760 of 898) with videos related to

Pageof 90
Sort By:
Biorxiv : the Preprint Server for Biology|September 5, 2025
TP53 mutations drive therapy resistance via post-mitochondrial caspase blockadeAhmed M Mamdouh, Elyse A Olesinski, Fang Qi Lim, et al.
Annals of Hematology|March 28, 2025
A phase 1 study of durvalumab as monotherapy or combined with tremelimumab with or without azacitidine in patients with myelodysplastic syndromeGuillermo Garcia-Manero, Manila Gaddh, Uwe Platzbecker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2001
Clinical evidence for topotecan-paclitaxel non--cross-resistance in ovarian cancerM Gore, W ten Bokkel Huinink, J Carmichael, et al.
The Journal of Trauma and Acute Care Surgery|May 12, 2022
A combat casualty relevant dismounted complex blast injury model in swineAlexis L Cralley, Ernest E Moore, Daniel Kissau, et al.
Brain : a Journal of Neurology|September 10, 2009
Symptoms 'unexplained by organic disease' in 1144 new neurology out-patients: how often does the diagnosis change at follow-up?Jon Stone, A Carson, R Duncan, et al.
Brain Stimulation|April 13, 2023
Focused ultrasound neuromodulation of the spleen activates an anti-inflammatory response in humansStavros Zanos, Despoina Ntiloudi, John Pellerito, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Docetaxel and cisplatin in combination as first-line chemotherapy for advanced epithelial ovarian cancer. Scottish Gynaecological Cancer Trials GroupP A Vasey, J Paul, A Birt, et al.
Retina (Philadelphia, Pa.)|December 30, 2009
Preliminary assessment of celecoxib and microdiode pulse laser treatment of diabetic macular edemaEmily Y Chew, Jonghyeon Kim, Hanna R Coleman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 11, 2012
Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month resultsR Coleman, R de Boer, H Eidtmann, et al.
Surgery|September 17, 2019
Whole blood thrombin generation is distinct from plasma thrombin generation in healthy volunteers and after severe injuryJulia R Coleman, Ernest E Moore, Jason M Samuels, et al.
Pageof 90

Showing results (751-760 of 898) with videos related to

Sort By:
Pageof 90
Biorxiv : the Preprint Server for Biology|September 5, 2025
TP53 mutations drive therapy resistance via post-mitochondrial caspase blockadeAhmed M Mamdouh, Elyse A Olesinski, Fang Qi Lim, et al.
Annals of Hematology|March 28, 2025
A phase 1 study of durvalumab as monotherapy or combined with tremelimumab with or without azacitidine in patients with myelodysplastic syndromeGuillermo Garcia-Manero, Manila Gaddh, Uwe Platzbecker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2001
Clinical evidence for topotecan-paclitaxel non--cross-resistance in ovarian cancerM Gore, W ten Bokkel Huinink, J Carmichael, et al.
The Journal of Trauma and Acute Care Surgery|May 12, 2022
A combat casualty relevant dismounted complex blast injury model in swineAlexis L Cralley, Ernest E Moore, Daniel Kissau, et al.
Brain : a Journal of Neurology|September 10, 2009
Symptoms 'unexplained by organic disease' in 1144 new neurology out-patients: how often does the diagnosis change at follow-up?Jon Stone, A Carson, R Duncan, et al.
Brain Stimulation|April 13, 2023
Focused ultrasound neuromodulation of the spleen activates an anti-inflammatory response in humansStavros Zanos, Despoina Ntiloudi, John Pellerito, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Docetaxel and cisplatin in combination as first-line chemotherapy for advanced epithelial ovarian cancer. Scottish Gynaecological Cancer Trials GroupP A Vasey, J Paul, A Birt, et al.
Retina (Philadelphia, Pa.)|December 30, 2009
Preliminary assessment of celecoxib and microdiode pulse laser treatment of diabetic macular edemaEmily Y Chew, Jonghyeon Kim, Hanna R Coleman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 11, 2012
Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month resultsR Coleman, R de Boer, H Eidtmann, et al.
Surgery|September 17, 2019
Whole blood thrombin generation is distinct from plasma thrombin generation in healthy volunteers and after severe injuryJulia R Coleman, Ernest E Moore, Jason M Samuels, et al.
Pageof 90